How you will be ranked, informed of your outcomes, how you will preference, how you will receive offers based on your scores and how references will be requested.

Ranking, outcomes and preferencing

Following interviews, you will receive a unique ranking. You will be deemed successful or unsuccessful and will be informed of this via Oriel.

Preferencing of posts will be available prior to offers being made. You will be able to preference posts as stated in the table above. For guidance on how to submit your preferences please refer to the Oriel Applicant User Guide.

Offers, references and scoresheet release

Offers will be made to those successful applicants that have ‘matched’ to a post and will be based on the your ranking and preferences. Offers will be made via Oriel on as stated in the table above.

Following initial offers being released, further offers will be made in subsequent iterations.

You will have 48 hours from the time of offer (excluding weekends) to confirm via Oriel whether you wish to accept, reject or hold your offer. Offers made after the hold deadline will only have the option to accept or reject.

References will only be requested when an offer has been accepted.

Scoresheets will be released to all applicants on a specified date and so you do not need to request your scoresheets after interview.

Allocations

Once you have accepted a Histopathology ST1 post, your information will be passed to the relevant region who will contact themyou directly to complete the allocation process.

Further information on how to request a deferred start date or training less than full time (LTFT) can be found on the Medical Specialty Recruitment page.

Next steps and roles and responsibilities

Your details will be passed on to the local training programme director around 14 weeks prior to your start date and to the first trust you have been appointed to 12 weeks prior to your start date. Therefore, you should not expect to receive any communication prior to this time.

Page last reviewed: 16 October 2023
Next review due: 16 October 2024